© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 30, 2021
Agency requests additional analyses on the novel mechanism of action on the serum phosphorus treatment for chronic kidney disease patients on dialysis.
April 29, 2021
New data show blood pressure lowering medication can be effective in reducing cardiovascular events in adults, regardless of blood pressure levels or history of cardiovascular risk.
Not all individuals with sarcoidosis need to be treated.
Researchers recently completed a 16-week phase 2b trial for patients with ulcerative colitis.
April 28, 2021
A study characterizing frailty in patients with rheumatoid arthritis finds psychosocial factors could be more important determinants than aging.
April 27, 2021
David I. Bernstein, MD of the University of Cincinnati College of Medicine discusses the recent approval of short ragweed pollen allergen extract tablet (RAGWITEK) for the treatment of children and adolescents.
April 26, 2021
While Janise Kinase inhibitors are a fraction of what’s to come in dermatology, research from AAD VMX 2021 shows they represent the potential of unlocking new capabilities across the field.
Jeffrey Stark, MD, of UCB discusses the promising data being generated by the robust trial program for plaque psoriasis.
Esther Freeman, MD, PhD, discusses the most frequent cutaneous presentations associated with vaccination.
An overview of standard treatment approaches approved to treat inflammatory bowel disease and recommendations for appropriately selecting therapy based on the disease’s clinical presentation.